MedTrace Logo

Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue

NCT02974751 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2019-10-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of the AQUABEAM System for the treatment of Lower Urinary Tract Symptoms (LUTS) resulting from Benign Prostatic Hyperplasia (BPH).

Conditions

  • BPH

Interventions

PROCEDURE

Aquablation

Aquablation is a minimally invasive transurethral surgical procedure using the AQUABEAM system, a personalized image-guided waterject resection system that utilizes a high-velocity saline stream to resect and remove prostate tissue.

Sponsors & Collaborators

  • PROCEPT BioRobotics

    lead INDUSTRY

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-05
Primary Completion
2019-05-24
Completion
2020-02-29

Countries

  • Australia
  • Germany
  • Lebanon
  • New Zealand
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02974751 on ClinicalTrials.gov